Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSDERMALStandard

TESTOSTERONE

TESTOSTERONE

Standard Dose
1.62% (40.5MG/2.5GM PACKET)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TESTOSTERONE is listed in Drugs@FDA under application 205781 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TESTOSTERONE Form and strength GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2019-06-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview TESTOSTERONE is listed in Drugs@FDA under application 205781 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TESTOSTERONE Form and strength GEL;TRANSDERMAL - 1.62% (40.5MG/2.5GM PACKET) Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2019-06-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.